Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

Associate Professor

Urology · Japan · 2025-04-23

Processing Time
112 days
Decision Date
2025-04-23
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner plans to serve as an adjunct assistant professor at a U.S. institution, focusing on developing macrophage-based molecular therapies to prevent kidney stone development. Additionally, they intend to create artificial intelligence-powered surgical instruments to enhance the safety and precision of urological procedures.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses pressing global health issues related to kidney stone production and obesity-related health problems.

2 Well-positioned to Advance the Endeavor Met

The petitioner is an established expert with over 100 publications and thousands of citations, ranking in the top 1.1% of authors in the field.

3 Balance of Interests Met

The petitioner's unique expertise in AI-assisted surgery and genomic urology makes their presence highly beneficial to the U.S. healthcare system.

Why This Petition Was Approved

The petition was approved based on a prolific record of 104 peer-reviewed journal articles and 2 book chapters, alongside 2,194 citations and an h-index of 24. The evidence included 93 peer reviews, editorial board service, and 8 expert recommendation letters confirming the petitioner's standing in the top 1.1% of their field.

Request for Evidence (RFE)

Successfully Addressed

The NIW petition faced an RFE that questioned the merits of the case; the legal team provided additional documentation to satisfy the Dhanasar criteria.

RFE Targets
Substantial Merit and National ImportanceWell-positioned to Advance the EndeavorBalance of Interests

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Judging Experience
Original Contributions

Similar Cases

Physician

Healthcare · Pakistan

WeGreened EB-2 (NIW) approved
Kentucky 2 days 2023-11-30
The petitioner proposes to develop strategies for early drug toxicity recognition, treatment implementation, and the use of novel therapies for chronic, rare, and evolving kidney diseases. This work aims to improve healthcare outcomes for high-risk patient populations and advance global knowledge in the field of nephrology.
View Case

Research Scientist

Healthcare · India

WeGreened EB-2 (NIW) approved
Massachusetts 20 days 2025-06-05
The petitioner proposes to advance the development of quantitative clinical decision-making tools to enable earlier and more precise interventions for chronic, life-altering diseases. Her work focuses on applying advanced epidemiological and statistical methods to create early detection protocols and personalized treatment strategies. The endeavor aims to improve patient outcomes in high-risk populations while reducing the economic burden of long-term disease management.
View Case

Doctor

Healthcare · Brazil

WeGreened EB-2 (NIW) approved
Georgia 303 days 2025-03-31
The petitioner proposes to continue his work as a urologist focusing on robotic surgery, erectile dysfunction, and urologic oncology. His work involves developing diagnostic and treatment strategies to enhance surgical outcomes and improve the quality of life for patients with prevalent men's health issues and urological cancers. The endeavor aims to expand the knowledge base in urology and support healthcare innovation through complex robotic interventions and outcomes-based clinical research.
View Case

Analyst

Research and Development · Nepal

WeGreened EB-2 (NIW) approved
Massachusetts 8 days 2023-03-14
The petitioner proposes to continue his research using statistical methodologies to design, conduct, and analyze clinical research studies. His work focuses on determining better treatment approaches for health disorders, identifying adverse health effects of past practices, and finding associations between exposures and existing health treatments.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from Japan

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-23.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 112 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Japan All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist